Clinical Trial Update: CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride [Phase 3]

View source ↗

Summary

A Phase 3 trial (CANTATA-SU) evaluating canagliflozin added to metformin versus glimepiride as add-on therapy in adults with type 2 diabetes; results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Amaryl (glimepiride)
• INVOKANA (CANAGLIFLOZIN)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2013-06-04